Suppr超能文献

老年男性前列腺癌确诊后的死因

Cause of death in older men after the diagnosis of prostate cancer.

作者信息

Ketchandji Melanie, Kuo Yong-Fang, Shahinian Vahakn B, Goodwin James S

机构信息

University of Texas Medical Branch, Galveston, Texas, USA.

出版信息

J Am Geriatr Soc. 2009 Jan;57(1):24-30. doi: 10.1111/j.1532-5415.2008.02091.x. Epub 2008 Nov 18.

Abstract

OBJECTIVES

To compare survival and cause of death in men aged 65 and older diagnosed with prostate cancer and with survival and cause of death in a noncancer control population.

DESIGN

Retrospective cohort from a population-based tumor registry linked to Medicare claims data.

SETTING

Eleven regions of the Surveillance, Epidemiology and End Results (SEER) Tumor Registry.

PARTICIPANTS

Men aged 65 to 84 (N=208,601) diagnosed with prostate cancer from 1988 through 2002 formed the basis for different analytical cohorts.

MEASUREMENTS

Survival as a function of stage and tumor grade (low, Gleason grade<7; moderate, grade=7; and high, grade=8-10) was compared with survival in men without any cancer using Cox proportional hazards regression. Cause of death according to stage and tumor grade were compared using chi-square statistics.

RESULTS

Men with early-stage prostate cancer and with low- to moderate-grade tumors (59.1% of the entire sample) experienced a survival not substantially worse than men without prostate cancer. In those men, cardiovascular disease and other cancers were the leading causes of death.

CONCLUSION

The excellent survival of older men with early-stage, low- to moderate-grade prostate cancer, along with the patterns of causes of death, implies that this population would be well served by an ongoing focus on screening and prevention of cardiovascular disease and other cancers.

摘要

目的

比较65岁及以上被诊断为前列腺癌的男性的生存率和死亡原因,以及非癌症对照人群的生存率和死亡原因。

设计

基于人群的肿瘤登记处与医疗保险索赔数据相链接的回顾性队列研究。

地点

监测、流行病学和最终结果(SEER)肿瘤登记处的11个地区。

参与者

1988年至2002年期间被诊断为前列腺癌的65至84岁男性(N = 208,601)构成了不同分析队列的基础。

测量

使用Cox比例风险回归比较前列腺癌患者按分期和肿瘤分级(低,Gleason分级<7;中,分级 = 7;高,分级 = 8 - 10)的生存率与无癌症男性的生存率。使用卡方统计比较按分期和肿瘤分级的死亡原因。

结果

早期前列腺癌且肿瘤分级为低至中度的男性(占整个样本的59.1%)的生存率并不比无前列腺癌的男性差很多。在这些男性中,心血管疾病和其他癌症是主要死亡原因。

结论

早期、低至中度前列腺癌的老年男性具有良好的生存率,以及死亡原因模式,这意味着持续关注心血管疾病和其他癌症的筛查和预防将使该人群受益。

相似文献

1
Cause of death in older men after the diagnosis of prostate cancer.
J Am Geriatr Soc. 2009 Jan;57(1):24-30. doi: 10.1111/j.1532-5415.2008.02091.x. Epub 2008 Nov 18.
2
Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer.
Eur Urol. 2015 Nov;68(5):805-11. doi: 10.1016/j.eururo.2015.03.021. Epub 2015 Mar 21.
3
Cause of death in older men after the diagnosis of prostate cancer.
J Am Geriatr Soc. 2009 May;57(5):934-5. doi: 10.1111/j.1532-5415.2009.02241.x.
4
Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
JAMA Netw Open. 2020 Mar 2;3(3):e201839. doi: 10.1001/jamanetworkopen.2020.1839.
5
Impact of comorbidity on survival among men with localized prostate cancer.
J Clin Oncol. 2011 Apr 1;29(10):1335-41. doi: 10.1200/JCO.2010.31.2330. Epub 2011 Feb 28.
8
Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
JAMA Oncol. 2019 Jan 1;5(1):60-66. doi: 10.1001/jamaoncol.2018.3701.
10
Temporal trends in cause of death among Swedish and US men with prostate cancer.
J Natl Cancer Inst. 2012 Sep 5;104(17):1335-42. doi: 10.1093/jnci/djs299. Epub 2012 Jul 25.

引用本文的文献

5
Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood.
Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077.
7
Ubiquitination Process Mediates Prostate Cancer Development and Metastasis through Multiple Mechanisms.
Cell Biochem Biophys. 2024 Mar;82(1):77-90. doi: 10.1007/s12013-023-01156-x. Epub 2023 Oct 17.
8
Cardiovascular mortality by cancer risk stratification in patients with localized prostate cancer: a SEER-based study.
Front Cardiovasc Med. 2023 Aug 4;10:1130691. doi: 10.3389/fcvm.2023.1130691. eCollection 2023.
10
Relationship between cigarette use and prostate cancer risk: what do we know and what should we do?
Prostate Cancer Prostatic Dis. 2023 Sep;26(3):516-518. doi: 10.1038/s41391-023-00671-5. Epub 2023 Apr 22.

本文引用的文献

1
Limits of observational data in determining outcomes from cancer therapy.
Cancer. 2008 Jun;112(11):2456-66. doi: 10.1002/cncr.23452.
2
Management of localized prostate cancer in senior adults: the crucial role of comorbidity.
BJU Int. 2008 Mar;101 Suppl 2:16-22. doi: 10.1111/j.1464-410X.2007.07487.x.
4
Deaths: leading causes for 2004.
Natl Vital Stat Rep. 2007 Nov 20;56(5):1-95.
9
Survival associated with treatment vs observation of localized prostate cancer in elderly men.
JAMA. 2006 Dec 13;296(22):2683-93. doi: 10.1001/jama.296.22.2683.
10
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.
J Clin Oncol. 2006 Sep 20;24(27):4448-56. doi: 10.1200/JCO.2006.06.2497.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验